Inhibition of apoptosis: potential clinical targets

MLA

Mark Alan Levy, et al. “Inhibition of Apoptosis: Potential Clinical Targets.” Emerging Drugs, vol. 3, June 1998, pp. 317–33. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........4a52691139ea5fdb3b167ff80505b4e2&authtype=sso&custid=ns315887.

APA

Mark Alan Levy, Michael F James, Mark E. Nuttall, & James D. Winkler. (1998). Inhibition of apoptosis: potential clinical targets. Emerging Drugs, 3, 317–333.

Chicago

Mark Alan Levy, Michael F James, Mark E. Nuttall, and James D. Winkler. 1998. “Inhibition of Apoptosis: Potential Clinical Targets.” Emerging Drugs 3 (June): 317–33. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........4a52691139ea5fdb3b167ff80505b4e2&authtype=sso&custid=ns315887.